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Introduction
The endoplasmic reticulum (ER) is the main Ca 2+ storage facility within cells. ER luminal Ca 2+ homeostasis and Ca 2+ signaling are partially maintained and controlled by Ca 2+ release via three isoforms of inositol 1,4,5-trisphosphate receptors (IP 3 Rs; Boehning et al. 2003) . In Chinese hamster ovary (CHO) cells, type 3 IP 3 R (IP 3 R3) resides at the direct ER-mitochondrion contact termed MAM (mitochondria-associated ER membrane) and specifically assist in mitochondrial Ca 2+ transfer (Mendes et al. 2005) . In fact, tethering proteins, such as mitofusin 2 (Mfn2), maintain a distance between the ER and the outer mitochondrial membrane (OMM) of 10-25 nm (Csordás et al. 2006; Hayashi et al. 2009 ). Thus, IP 3 R associate with VDAC on the OMM, through glucose-regulated protein 75, to ensure a large localized increase in Ca 2+ concentration is obtainable to stimulate mitochondrial Ca 2+ uptake (Szabadkai et al. 2006) . In addition, the sigma-1 receptor (Sig-1R), in conjunction with binding immunoglobulin protein (BiP), forms a complex that stabilizes IP 3 R3s at the MAM to prevent degradation and prolong transient Ca 2+ signals (Hayashi and Su 2007; Su 1982; Snyder and Largent 1989; Largent et al. 1984) . This direct mitochondrial Ca 2+ transfer plays a critical role in the activation of bioenergetics (Cárdenas et al. 2010; Rizzuto et al. 2012; Hammerman et al. 2004) . In fact, Ca 2+ regulates mitochondrial ATP production by targeting Ca 2+ − dependent enzymes of the TCA cycle (pyruvate, isocitrate, and α-ketoglutarate dehydrogenases) and the electron transport chain as well as ATP synthase and the ATP translocator (Ezawa and Ogata 1979; Bender and Kadenbach 2000; Kirichenko et al. 1998; Hubbard and McHugh 1996; Das 2003; Beis and Newsholme 1976; Jouaville et al. 1999; Wan et al. 1989) .
Prolonged Ca 2+ signals or mitochondrial Ca 2+ overload disable energetic pathways leading to apoptosis (Pinton et al. 2002) . Several members of the Bcl-2 family, known regulators of apoptosis, have also emerged as competitive regulators of intracellular Ca 2+ at the ER ). This includes anti-apoptotic Bcl-2 and Bcl-x L . Both of which bind all three isoforms of IP 3 R (Eckenrode et al. 2010) and are known to alter transient Ca 2+ signals into the cytosol (Eno et al. 2012; Rong et al. 2008; White et al. 2005) . It has also been postulated that Bcl-x L regulation of IP 3 R-mediated Ca 2+ signals aid in increasing NADPH levels (White et al. 2005) . However, direct mitochondrial Ca 2+ measurements have not been examined. Thus, Bcl-2 family protein involvement in direct ER to mitochondrial Ca 2+ signaling is unknown. Therefore, we explore the localization and role of Bcl-x L in the regulation of IP 3 R3-mediated mitochondrial Ca 2+ signaling and bioenergetics as well as its dynamics in CHO cells following stimulus of ER stress.
Herein, Bcl-x L is shown to reside partially at the MAM, where its BH4 domain is important for IP 3 R3 binding. This interaction facilitates the redistribution of Ca 2+ from the ER to the mitochondria to promote TCA cycle activity, while lowering the transfer of Ca 2+ into the cytosol. Furthermore, we found that Bcl-x L translocates to the MAM during ER stress in order to increase interaction with IP 3 R3 enriched at the MAM. Thus, Bcl-x L might exist at the MAM to play an integrating role in bioenergetics and cellular survival by regulating direct mitochondrial Ca 2+ transients from the ER.
Results
Bcl-x L resides at mitochondria-associated ER membrane (MAM).
To explore the localization of Bcl-x L , we fractionated CHO-K1 and CHO-Bcl-x L (CHO-K1 cells stably overexpressing Bcl-x L ) cells into its subcellular compartments (Fig. 1a) . Analysis of fractions indicated that endogenous Bcl-x L was predominately a mitochondrial protein (51 ± 1 %); however, a smaller but distinct amount (12.1 ± 0.8 %) resides in MAMenriched fractions. The remaining cellular Bcl-x L was found in whole cell/nuclear (P1), microsomal (P3; vesicle-like artifacts that form from ER fragments), and cytosolic (Cyto) fractions. Overexpressing Bcl-x L resulted in an overall increase in Bcl-x L protein (Fig. 1b) , although similar percentages of Bcl-xL were observed in most cellular compartments following fractionation ( Fig. 1a and Supplemental Figure S1A ). An increase in Bcl-x L detected in the cytosolic fraction was observed, and may be attributed to the abundance of heterologous Bcl-x L in the overexpressed system. Detection of known nuclear (nucleoporin 62; NP62), mitochondrial (cytochrome c), ER (endoplasmic reticulum resident protein 75; ERp57), MAM (IP 3 R3 and Sig-1R), and cytosolic (GAPDH) proteins were used to validate the purity of individual fractions.
Cells were additionally exposed to an alkali treatment (100 mM NaCO 3 for 30 min) to determine whether Bcl-x L binds integrally with cellular membranes (Fig. 1c) . Prior to treatment, Bcl-x L was observed to reside mostly in crude mitochondria fractions (containing MAM). However, after the addition of NaCO 3 , a majority of endogenous and overexpressing Bcl-x L was observed in the cytosolic fraction. IP 3 R3, a known integral membrane-bound protein used for comparison, resided in membrane fractions before and after alkali treatment. Thus, Bcl-x L was loosely attached to cellular membranes, which could explain, at least in part, how Bcl-x L was found in multiple compartments including the mitochondria, MAM, and cytosol.
Bcl-x L interacts with IP 3 Rs and enhances direct mitochondrial Ca 2+ signaling at the MAM Given our data indicating Bcl-x L partially localizes at the MAM (Fig. 1a) and that IP 3 R3 is highly enriched at the MAM, we investigated the interaction of Bcl-x L with IP 3 R3 in more detail. IP 3 R3 was observed to co-precipitate with Bclx L in CHO-Bcl-x L cells transiently transfected with IP 3 R3 (Fig. 2a) . In addition, the binding of Bcl-x L with endogenous IP 3 R3 was investigated by nickel pull-down in CHO-K1 cells transiently expressing full-length, BH4-truncated (ΔBH4), or transmembrane (TM) domain-truncated (ΔTM) polyhistidine (His)-tagged Bcl-x L constructs (Fig. 2b) . We confirm the interaction of full-length Bcl-x L with endogenous IP 3 R3 and normalize this IP 3 R3/Bcl-x L interaction to 100 % (Fig. 2c) . In comparison, IP 3 R3 binding with Bcl-x L ΔBH4 (Bcl-x L lacking the BH4 binding domain giving it its anti-apoptotic activity) was reduced by more than half (44 ± 8 %), and an even greater reduction in IP 3 R3 interaction was detected when the TM domain of Bcl-x L was removed causing Bcl-x L to become cytosolic, although all of its binding regions remain intact-10 ± 5 % for Bcl-x L -ΔTM (Zheng et al. 2008) . Thus, the localization of Bcl-x L to cellular membranes, including the mitochondria and the MAM, and its BH4 binding domain appear to play a role in IP3R3 interaction. Since IP 3 R3 regulates mitochondrial Ca 2+ signaling at the MAM (Mendes et al. 2005; Blackshaw et al. 2000; Marchi et al. 2012; Bononi et al. 2013 ), a potential non-apoptotic functional role for Bcl-x L was explored. We treated cells with 500 nM thapsigargin (Tg) to induce depletion of ER Ca
2+
. It is important to note that apoptosis is not induced during the time periods considered in this study. In fact, apoptosis was not significantly activated in either cell line following 3 h Tg treatment as indicated by Annexin V positive cells (Fig. 3a) , when compared to known apoptosis-inducing compounds staurosporine and camptothecin (Zhang et al. 1998; Gülçe Iz et al. 2012; Hinz et al. 2003) . We also evaluated Annexin V positive cells following 12 h Tg treatment, and noted a slight but significant increase in CHO-K1 cells (Fig. 3a) . Additionally, there was not a significant increase in caspase 3/7 activity after 3 or 12 h Tg treatment in either cell line ( Fig. 3b and Supplemental Figure S2 ). We monitored intracellular Ca 2+ after Tg-induced ER Ca 2+ depletion in co-cultured control and Bcl-x L overexpressing cells to allow for comparisons under the same microscopy field. HcRed-labeled cell lines (CHO-HcRed and CHO-HcRed-Bcl-x L ) were used to were used to monitor mitochondrial Ca 2+ using X-Rhod-5f AM, a red-fluorescent Ca 2+ indicator. Bcl-x L expression in these cell lines is provided in Supplemental Figure S1B . No significant difference in the rate of intra-ER Ca 2+ depletion was detected in Bcl-x L overexpressing cells compared to control cells (Fig. 4a) . However, Bcl-x L overexpressing cells showed a reduced flux of Ca 2+ transients into the cytosol (Fig. 4b) , and interestingly, an increase in transient mitochondrial Ca 2+ influx ( Fig. 4c and Supplemental Figure S3A ) following Tg stimulation.
Furthermore, we monitored cytosolic and mitochondrial Ca 2+ in CHO-Bcl-x L cells following a reduction in IP 3 R3 levels in CHO-Bcl-x L cells using siRNA (Fig. 4d ). Null cells (cells not treated with siRNA) were co-cultured with cells transfected with either control (CNT) siRNA or siRNA targeted to IP 3 R3, and either YFP or HcRed vector (depending on the fluorescence of the Ca 2+ indicator used) in order to distinguish between null and siRNA treated cells. While IP 3 R3 knockdown had no significant effect on Ca 2+ transients into the cytosol (Fig. 4e) , an abrogation of mitochondrial Ca 2+ transfer was observed when compared to null and CNT siRNA treated cells (Fig. 4f ). An observed change in the initial slope of mitochondrial Ca 2+ transients following CNT siRNA treatment is noted (Fig. 4f) ; however, nonspecific effects are common (Scacheri et al. 2004 ) and we expected to see some changes compared to cells without any siRNA. Similar results were also seen in CHO-K1 cells following Fig. 3 Limited thapsigargin treatment does not induce apoptosis. a In comparison to known apoptosis-inducing compounds, staurosporine (3 uM STA, 4 h) or camptothecin (50 uM Camp, overnight), there is not a significant increase in apoptosis due to prolonged treatment with Tg as indicated by Annexin V positive cells (n = 3). b There is not a significant activation of caspase 3/7 activities in comparison to known apoptosisinducing compounds (STA or Camp) following prolonged Tg treatment (n = 3). 500 nM Tg treatment was used for all experiments. *P < 0.05 versus control at identical time point. **P < 0.05 versus non-treated control of the same cell line IP 3 R3 knockdown (Supplemental Figure S3B-C) . In contrast, we did not observe any significant differences in mitochondrial Ca 2+ transients following knockdown of IP 3 R1 and IP 3 R2 (data not shown). These findings suggest that increased levels of Bcl-x L , particularly at the MAM, serve to aid in the distribution of ER Ca 2+ transients into the mitochondria.
Bcl-x L expression enhances Ca 2+ − dependent bioenergetics
Metabolic phenotyping was performed in order to examine whether there are any bioenergetic implications of Ca 2+ redistribution due to Bcl-x L expression. Microarray plates were used to measure the metabolic consumption of nine metabolites that feed into the TCA cycle (D-mannose, D,L-lactate, pyruvate, α-keto-glutarate, succinamic acid, succinate, monomethyl succinate, adenosine, and inosine) as a function of NADH flux (Supplemental Figure S4 ). Wells containing glucose served as a positive control, while tricarballylic acid wells functioned as a negative control by hindering the conversion of citrate in the TCA cycle (Russell and Forsberg 1986) . Utilization rates of substrates were normalized to the slope of glucose consumption, and overall, Bclx L overexpressing cells tended to consume these metabolic substrates at a higher rate than controls (Fig. 5a ). Additionally, endogenous lactate accumulation was measured on a per cell basis, and CHO-Bcl-x L accumulated lower levels of lactate compared to controls (Fig. 5b) , suggesting pyruvate is shuttled into the TCA cycle more efficiently in these cells.
NAD/NADH ratio was also investigated since NAD is reduced to NADH in the TCA cycle. Compared to control cells, (−) KHB. a Net FRET (nF) measurement, FRET measurement corrected for background, of ER Ca 2+ using D1ER Ca 2+ cameleon shows no significant difference in ER Ca 2+ depletion in Bcl-x L overexpressing cells compared to control (n = 3). b ER to cytosol Ca 2+ influx was measured using Fluo-4 AM Ca 2+ dye (n = 5). A smaller increase in cytosolic Ca 2+ influx was observed in Bclx L overexpressing cells. c ER to mitochondria Ca 2+ influx was measured using X-Rhod-5f AM Ca 2+ dye (n = 5). A larger increase in mitochondrial Ca 2+ influx was observed in Bcl-x L overexpressing cells relative to control cells. d CHO-Bcl-x L cells were transfected with non-active control siRNA (CNT siRNA) or siRNA targeting IP 3 R3. Ca 2+ signaling was compared in co-cultured null (non-siRNA treated) cells and siRNA treated (CNT or IP 3 R3) cells. e Knocking down IP 3 R3 does not affect ER to cytosolic Ca 2+ transfer, but f significantly diminishes ER to mitochondrial Ca 2+ transfer in CHO-Bcl-x L cells (n = 3). All data represented as mean ± SEM. *P < 0.05 versus control. AUC, or area under the curve, is provided as a comparison of calcium transients between cell lines, as it takes into account differences in the fluorescence baseline fluorescence between cells
Bcl-x L overexpressing cells had higher levels of NADH relative to NAD, thus the NAD/NADH ratio was lower (Fig. 5c ), which indicate Bcl-x L overexpressing cells have a more active TCA cycle compared to controls. Cells were also subjected to short treatments with Tg (15 or 30 min) to induce increases in mitochondrial Ca 2+ as previously observed in Fig. 3c . Under these conditions, NAD/NADH ratios decreased in both cell lines, although ratios still tend to remain lower in Bcl-x L overexpressing cells (Fig. 5c ). In contrast, higher NAD/NADH ratios were noted in both cell lines after IP 3 R3 was knocked down and remained high following 30 min treatment with Tg (although a slight drop was noted in the CHO-Bcl-x L cells which can be attributed to the remaining IP 3 R3 following knockdown), while CNT siRNA had no significant affect in comparison to controls (Fig. 5d) .
NADH generated from the TCA cycle is subsequently fed into the electron transport chain (ETC.) where it is oxidized by enzymes known as oxidoreductases. Therefore, we used a chemiluminescence assay to monitor the activity of mitochondrial oxidoreductases of the ETC. (ETC oxidase activity) in cells stimulated with NADH (Michel et al. 1998; Lu et al. 2007 ). Interestingly, Bcl-x L overexpressing cells were observed to have higher ETC oxidase activity compared to control cells following stimulation with NADH ( Fig. 5e) , and similar results were seen using YFP-and HcRed-tagged Bcl-x L and their control counterparts (Supplemental Figure S5) . Additionally, the inclusion of chemicals that change intracellular Ca 2+ availability were shown to alter ETC oxidase activity ( Fig. 5e ), especially for Bcl-x L overexpressing cells. For example, 30 min incubation with Tg increased ETC oxidase activity. Whereas, treating cells for 30 min with BAPTA-AM, a Ca 2+ chelator that reduces intracellular Ca 2+ concentration, hindered ETC oxidase activity even after an additional treatment with Tg. Thus, ETC activity appears to be dependent on Bcl-x L levels and Ca 2+ availability, perhaps as a result of more rapid TCA cycling and NADH turnover. Taken together, the data indicates that Ca 2+ redistribution as a result of Bcl-x L overexpression alters mitochondrial metabolism and NADH generation.
Bcl-x L translocates to the MAM and increases bioenergetic capacity following thapsigargin-induced ER stress
We were also interested in determining how Bcl-x L expression affects bioenergetics under stress conditions. While we have shown that 3 h treatment with Tg does not stimulate apoptosis are observed when IP 3 R3 is knocked down using siRNA compared to null cells, while control (CNT) NADH ratios/NADH ratios (n = 3). (Di) Electron transport chain (ETC.) oxidase activity is higher in Bcl-x L overexpressing cells compared to controls in non-treated cells (n = 6). Pre-incubation with (Dii) Tg, (Diii) BAPTA-AM, a Ca 2+ chelater, (Div) or a combination of both also alters NADH oxidation (n = 3). ROC, rate of change. All data is represented as mean ± SEM. *P < 0.05 versus control at identical time point. **P < 0.05 versus non-treated, or initial time point, control of the same cell line (Fig. 3) , prolonged Tg treatment has previously been shown to cause ER stress in CHO cells (DuRose et al. 2006 ), so we investigated whether ER stress is activated in our cells after extended periods of Tg insult. Following a 1 or 3 h incubation with Tg, we did not see any changes in endogenous or overexpressed Bcl-x L expression levels (Fig. 6a) . However, we did observe an upregulation of phosphorylated PERK (pPERK), an ER resident protein that becomes activated during ER stress (Mori et al. 2013) , in both cell lines after 1 or 3 Tg treatment (Fig. 6b) . Although, significantly more upregulation of pPERK was observed in CHO-K1 cells in comparison to pPERK upregulation in Bcl-x L overexpressing cells.
Since extended Tg treatment induces ER stress in our cells, we next examined for potential bioenergetic implications. NAD/NADH ratios were reduced in both control and Bcl-x L overexpressing cells after 1 h Tg treatment, and even more so after 3 h incubation (Fig. 6c) . Furthermore, ETC oxidase activity increased to a greater extent following NADH stimulation in both cell lines after 3 h Tg treatment when compared to the increase in activity without any Tg (Fig. 6d) . Pre-treating cells with BAPTA again diminished increases in ETC oxidase activity due to Tg stimulation (Fig. 6d) . Overall,TCA cycle activity again remained higher in Bcl-x L overexpressing cells. Given this information and that we previously show that MAMassociated Bcl-x L aids in stimulating TCA cycle activity, we investigated whether Bcl-x L localization at the MAM was altered before and after prolonged Tg treatment.
Endogenous Bcl-x L levels did not provide sufficient signal to quantify Bcl-x L localization by microscopy. Thus, immunostained CHO-Bcl-x L cells transiently transfected with GFPmito, a mitochondrial marker, were examined by 3D confocal microscopy ( Fig. 7a) . After imaging 50 individual cells and isolating 300 individual mitochondria, we found that mitochondria-associated Bcl-x L existed predominately in clustered form on or around mitochondria. As such, Bcl-x L was categorized into three distribution patterns based on its relation to mitochondria-Type 1: Clustered on mitochondria, Type 2: Clustered next to mitochondria, and Type 3: Evenly distributed, or not clustered, on mitochondria (Fig. 7b) . The characterization of Bcl-x L into these distribution patterns was determined by first distinguishing between Bcl-x L that was either in clustered form or non-clustered form. Those that were in non-clustered form were characterized together as Type 3, and later found to have >80 % of Bcl-x L colocalized with mitochondria. Next, Bcl-x L in clustered form was additionally observed to either overlap, or sit adjacent to the mitochondria marker. Therefore, we further distinguished clustered Bcl-x L based on its colocalization with mitochondria. Those that had ≥50 % of Bcl-x L colocalized with mitochondria were characterized as Type 1, and those that had <50 % of Bcl-x L colocalized with mitochondria were characterized as Type 2 (data not shown). Overall, ETC. oxidase activity remains higher in Bcl-x L expressing cells. ROC, rate of change. 500 nM Tg treatment was used for all experiments. All data represented as mean ± SEM for three independent experiments. *P < 0.05 versus control at identical time point. **P < 0.05 versus non-treated control of the same cell line
We then grouped individual mitochondria based on the aforementioned distribution patterns of associated Bcl-x L (Fig. 7c) . Mitochondria with exclusively Type 1 Bcl-x L were the most prominent (43 ± 4 %), while 23 ± 4 % of mitochondria exhibited Bcl-x L in a Type 2 pattern and 1.4 ± 0.8 % of mitochondria were observed with Type 3 Bcl-x L . The remaining~30 % of mitochondria were observed to have more than one type of cluster or have a combination of evenly distributed and clustered Bcl-x L forms. Similar Bcl-x L distribution patterns were observed when alternatively using endogenous Tomm20 as a mitochondrial marker, and with CHO-K1 cells stably overexpressing varying levels of YFP-or HcRedtagged Bcl-x L (Supplemental Figure S6A-C) . Additionally, we observed that mitochondrial staining was similar in CHO-K1 and CHO cells expressing various levels of Bcl-x L (Supplemental Figure S6D) .
Clustered Type 1 and Type 2 Bcl-x L were examined further to determine if they might associate with the MAM. Confocal microscopic examination was repeated as previously described with the addition of a MAM marker protein, IP 3 R3, and Mfn2, a MAM-mitochondria tethering protein (Supplemental Figure S7A) . In Fig. 7d , Type 1 Bcl-x L was observed to sit adjacent to the MAM and a fraction even colocalized with IP 3 R3 (18 ± 2 %) and Mfn2 (17 ± 3 %). Type 2 Bcl-x L also sat adjacent to MAM markers (Fig. 7d) . However, we detected greater colocalization with IP 3 R3 (38 ± 5 %), and interestingly 76 ± 4 % of the Type 2 Bcl-x L colocalized with Mfn2. This data indicates that Type 2 Bcl-x L Fig. 7 Three distinct patterns of Bcl-x L in relation to mitochondria. a Immunostaining of CHO-Bcl-x L (red) transiently transfected with GFPmito (green). Areas in which Bcl-x L and mitochondria co-localize are observed in yellow. Scale bar = 10 μm. b Bcl-x L was categories into three distribution patterns based on its relation to mitochondria-Type 1: clustered residing on mitochondria (≥50 % Bcl-x L colocalization), Type 2: clustered adjacent to mitochondria (<50 % Bcl-xL colocalization), or Type 3: evenly distributed on mitochondria. c Mitochondria with exclusively Type 1 Bcl-x L were the most prominent, followed by mitochondria exhibiting Bcl-x L exclusively in a Type 2 pattern. Only a small percentage of mitochondria were observed exclusively with Type 3 Bcl-x L . Data represented as mean ± SEM (n = 300). Scale bar = 2 μm. d Immunostaining and co-localization of Type 1 and Type 2 Bcl-x L (red) with GFP-mito (green) and MAM marker proteins (blue)-IP 3 R3 and Mfn2 (a MAM-mitochondria tethering protein). Data represented as mean ± SEM (n = 6). Scale bar = 2 μm. e Schematic representation of mitochondria with Type 1 and Type 2 Bcl-x L and its association with the MAM are depicted was clustered alongside mitochondria in the region associated with the MAM, and can be explained in part by our findings in Fig. 1c showing that Bcl-x L is a peripherally-attached membrane-bound protein. Furthermore, Bcl-x L colocalization with other ER-resident proteins enriched at the MAM-Sig-1R and BiP-was found to be similar to that of IP 3 R3 (Supplemental Figure S7A-B) . Thus, a putative schematic representative of Type 1 and Type 2 Bcl-x L association with mitochondria and MAM markers is illustrated in Fig. 7e . Of note, we did not observe significant co-localization between MAM marker proteins and GFP-mito, with the exception of Mfn2 (Supplemental Figure S7C) .
Next, we examined the effect of extended Tg treatment on Bcl-x L localization. In immunostained CHO-Bcl-x L cells, the percentage of mitochondria with exclusively Type 1 Bcl-x L decreased from 43 ± 4 % to 4 ± 2 % follow 3 h Tg treatment, while there was a corresponding increase in mitochondria with Type 2 MAM-associated Bcl-x L from 23 ± 4 % to 59 ± 5 % (Fig. 8a) . Likewise, in living cells, YFP-tagged Bcl-x L colocalization with mitochondria, labeled with DsRed-mito, decreased from 73 ± 3 % to 44 ± 4 % during 3 h incubation with Tg (Fig. 8b) . Moreover, results from cell fractionation indicate that Bcl-x L in MAM-enriched fractions increased following 1 or 3 h Tg treatment (Fig. 8c) . Tg-stimulated translocation of Bcl-x L was also observed to increase total cellular interaction of Bcl-x L with IP 3 R3 as detected by immunoprecipitation (Fig. 8d) and nickel pull-down (Fig. 8e) . Taken together, these data indicate that Tg-induced ER stress triggers Bcl-x L translocation to the MAM region where it increases its interaction with IP 3 R3, known to be enriched at the MAM, in order to alter cellular bioenergetics. Furthermore, we note the same tendency in cells treated with tunicamycin over an extended period of time (Supplemental Figure S2 and S8).
Discussion
Bcl-x L has previously been determined to reside predominately at the mitochondria at both the inner and outer membranes (Chen et al. 2011; Kaufmann et al. 2003) , which correlates with a another study that shows that the X-TMB sequencethe C-terminal transmembrane (TM) domain of Bcl-x L flanked by two basic regions, namely X and B-is responsible for mitochondrial targeting (Kaufmann et al. 2003) . However, Bcl-x L is also known to be partially present at the ER and within the cytosol (Tagami et al. 2000) . Our subcellular fractionation study is in agreement with these previous observations and we find that a majority of peripherally bound Bcl-x L resides in mitochondria-enriched fractions, and is also present in microsomal (ER) and cytosolic fractions. Interestingly, we also observed for the first time that Bcl-x L was partially localized in MAM-enriched fractions. This data is consistent with a previous study by our group in which Bcl-2 was observed to reside in part at the MAM (Meunier and Hayashi 2010) . However, there has been little investigation to determine if Bcl-2 family members serve a specific role at this cellular location. Thus, in this study we explored the functional implications of Bcl-x L at the MAM under non-apoptotic conditions.
Bcl-x L has previously been found to physically interact with all three isoforms of IP 3 Rs (White et al. 2005; Eckenrode et al. 2010) , and modulate the expression of type 1 and 3 IP 3 Rs (Li et al. 2002) . We confirmed the interaction of Bcl-x L with IP 3 R3, which is known to be enriched at the MAM, and additionally determined that the BH4 domain of Bcl-x L may be particularly relevant for IP 3 R3 binding. Previous results indicate that the BH4 domain of Bcl-2 is required for interaction with domain 3 of IP 3 Rs. However, the BH4 domain of Bcl-x L was not observed to bind this domain (Monaco et al. 2012; Rong et al. 2009 ), but fulllength Bcl-x L was found to bind domain 6 of IP 3 R (White et al. 2005) . Membrane targeting of Bcl-x L also seems to be crucial for Bcl-x L interaction with IP 3 R3 as indicated by the limited interaction of Bcl-x L ΔTM with IP 3 R3, since Bcl-x L is cytosolic when lacking its TM domain (Zheng et al. 2008 ).
Due to its interaction with IP 3 R3, a possible functional role for Bcl-x L in IP 3 R3-mediated Ca 2+ signaling was investigated (Szabadkai et al. 2006 ). In the current study, there was relatively little difference in the rate of Tg-induced ER Ca 2+ depletion in CHO-K1 and CHO-Bcl-x L cells expressing endogenous levels of all isoforms of IP 3 R. This is consistent with a previous report showing Bcl-x L expression had no effect on releasable ER Ca 2+ stores in CHO cells stably expressing ryanodine receptors, an ER Ca 2+ release channel (Pan et al. 2000) . However, the role of Bcl-x L in ER luminal Ca 2+ homeostasis appears to be cell type dependent. For instance, reduced ER luminal Ca 2+ in DT40 cells expressing Bcl-x L was attributed to IP 3 R3 expression (Li et al. 2007) , and a Bcl-x L variant targeted to the ER was shown to reduce ER Ca 2+ stores in MEF cells (Eno et al. 2012) . Nonetheless, we saw limited increases in cytosolic Ca 2+ levels in Bcl-x L overexpressing cells immediately following short-term Tg stimulation that is in agreement with past studies (White et al. 2005; Chen et al. 2004; Distelhorst and Shore 2004 Indeed, a recent report shows that Bcl-x L knock-out in MEF cells reduces mitochondrial Ca 2+ uptake relative to controls, while mitochondria-targeted Bcl-x L was shown to enhance mitochondrial Ca 2+ uptake by interacting with VDAC in permeabilized cells (Huang et al. 2013) . While these three alternatives are in fact complementary, further investigations will be required to elucidate the specific mechanism(s) by which Bcl-x L serves to enhance direct mitochondrial Ca 2 + shuttling. Nonetheless, our current study sheds light on at least one mechanistic pathway for explaining the drop in mitochondrial Ca 2+ uptake previously observed in MEF cells lacking Bcl-x L (Huang et al. 2013) .
This study additionally provides support to the notion that Bcl-x L evolved to include multiple intracellular functionalities. We propose that Bcl-x L plays a critical role in bioenergetics as a result of increases in direct ER to mitochondrial Ca 2+ transfer. This mitochondrial stimulation is known to increase Ca 2+ − dependent enzymes of the TCA cycle in order to provide sufficient energy to promote proper cell functioning (Cárdenas et al. 2010; Hammerman et al. 2004; Rizzuto et al. 2012) . Indeed, our data show that Bcl-x L overexpression causes global increases in metabolite consumption, decreases in lactate accumulation, lower NAD/NADH ratios, and higher ETC oxidase activity that suggest Bcl-x L overexpression alters TCA cycle activity in particular. Other mechanisms, such as an increase in metabolic transporters, may also play a role. Previous studies also support a role for Bcl-2 family proteins in altering cellular metabolism. For example, Bcl-x L expression was found to increase resting NADPH levels in DT40 cells (White et al. 2005) . Bcl-2 increased oxygen consumption and rates of mitochondrial respiration Pervaiz 2007, 2010) . Furthermore, overexpression of Bcl-2 family proteins in various cell lines reduces lactate accumulation (Dorai et al. 2009; Jeon et al. 2011) . A study in CHO-S cells overexpressing Bcl-2Δ showed that reduced lactate was the result of the redirection of pyruvate toward mitochondrial Fig. 8 Bcl-x L translocates to MAM following thapsigargin treatment. a Tg treatment (3 h) resulted in an increase in the number of Type 2 Bcl-x L , and a corresponding decrease in Type 1 Bcl-x L in immunostained CHOBcl-x L cells (n = 300). b Decreased Bcl-x L co-localization with mitochondria was observed during live-cell imaging of CHO-YFP-Bclx L cells transiently transfected with DsRed-mito and incubated with Tg over a 3 h time-span (n = 3). Bcl-x L is depicted in green and mitochondria is depicted in red, while overlapping is depicted in yellow. Bcl-x L colocalization with mitochondria decreases after Tg treatment, and more distinct green and red fluorescence is observed. c Cell fractionation studies showed decreases in overexpressed Bcl-x L at mitochondriaenriched fractions, and corresponding increases at MAM-enriched fractions after prolonged Tg treatment (1 and 3 h). Additionally, Tg treatment increased interaction of Bcl-x L with IP 3 R3 over a 3 h timespan as indicated by d immunoprecipitation and e nickel pull-down. 500 nM Tg treatment was used for all experiments. Data is represented as mean ± SEM (n = 3). *P < 0.05 versus non-treated control oxidation to stimulate TCA cycle activity (Templeton et al. 2014) .
We additionally determined that Bcl-x L expression affects bioenergetics under stress conditions after a closer inspection of Bcl-x L localization at the MAM following prolonged Tg treatment. Indeed, we provide evidence of the first case of Bclx L reorganizing to the MAM during an ER stress event. By confocal microscopy analysis, we observed three distinct distribution patterns of membrane-bound Bcl-x L in relation to mitochondria: (1) Clustered on mitochondria, (2) Clustered next to mitochondria, and (3) Evenly distributed on mitochondria. Type 2 Bcl-x L was of particular interest as it was found to associate most significantly with the MAM. Following extended Tg treatment, which induces ER stress but does not stimulate apoptosis, we observed Bcl-x L translocation from the mitochondria to the MAM and an increase in Bcl-x L interaction with IP 3 R3. Increased Bcl-2 and Bcl-x L interaction with IP 3 R3 has also been observed after apoptosis is induced with tyrosine kinase inhibitors (Zannetti et al. 2008) . We postulate that this interaction is localized to the MAM and believe the reason is to drive Ca 2+ transients into the mitochondria as a way to stimulate TCA cycle activity.
Bcl-x L regulation of bioenergetic pathways would be particularly important during times of cellular stress. We found that Bcl-x L expression is able to modulate cellular response to ER stress induced by sustained Tg treatment by increasing the bioenergetic capacity of the cell. We observed significant reduction in the upregulation of ER stress in cells overexpressing Bcl-x L , as indicated by reduced increases in pPERK (Su et al. 2008 ). This is accompanied by a further reduction in NAD/NADH ratios and even greater ETC oxidase activity in cells following prolonged Tg insult, and is consistent with previous reports showing an increased metabolic need in cells during times of stress (Duchen 2004; Gautier et al. 2008; Addabbo et al. 2009 ). In fact, ATP production is necessary for maintaining cell functioning, and a reduction in ATP levels and the ability of cells to handle nutrient stress was observed in Drosophila mutants without the Bcl-2 family protein Buffy (Monserrate et al. 2012 ). The ER, in particular, requires an adequate supply of energy to promote proper protein folding and clearance of misfolded proteins (Berridge 2002; Görlach et al. 2006; Hoseki et al. 2010) . Thus, increasing mitochondrial Ca 2+ transients to promote cellular metabolism can represent a means of trying to fend off insults during the adaptive stress response, whereas cells with impaired ER to mitochondrial Ca 2+ transport are more susceptible to apoptosis (JahaniAsl et al. 2007; Brooks et al. 2011) . In fact, an increase in the physical connection of the ER and mitochondria was observed during the very early stages of ER stress and was shown to support mitochondrial Ca 2+ transport (Bravo et al. 2011 ). These increases in MAM contact sites may be supported by Mfn2 tethering of the MAM and mitochondria. In a recent study, an upregulation of Mfn2 mRNA and protein levels was demonstrated, but no change in the expression of mitochondria shaping proteins was detected, following Tg-or tunicamycin-induced ER stress (Ngoh et al. 2012) . These data once again support our observations showing Bcl-x L translocation from mitochondria to the MAM. Possibly due to an increase in the number of ER-mitochondria contact sites during sustained Tg treatment.
The ability of Bcl-x L to control mitochondrial Ca 2+ homeostasis in order to maximize bioenergetics may ultimately be undermined during the initiation of apoptosis. Indeed, proapoptotic proteins Bax/Bak and tBid activated during ER stress (Upton et al. 2008 ) displace Bcl-2/Bcl-x L interaction with type 1 IP3R (Oakes et al. 2005; White et al. 2005) , while Bax/Bak were additionally shown to increase ER Ca 2+ leakage (Scorrano et al. 2003; Oakes et al. 2005) . Sustained Ca 2+ leakage directly into the mitochondria has been linked to the modulation and upregulation of IP 3 R3 (Giorgi et al. 2010; Blackshaw et al. 2000; Marchi et al. 2012; Bononi et al. 2013 ) and MAM integrity (Betz et al. 2013) . Ultimately, mitochondrial Ca 2+ overload will disable metabolic pathways and lead to apoptosis (Pinton et al. 2002) . As a result, cytochrome c is released into the cytosol where it is then able to bind IP 3 Rs to boost apoptotic Ca 2+ signals (Boehning et al. 2003) . Thus, our findings suggest that non-apoptotic Bcl-x L regulation of mitochondrial Ca 2+ , particularly at the MAM, is especially complex and multifunctional with a very stringent yet fine control that responds differently to various levels of cellular stress.
Materials and methods
Cell culture and transfection
All cells were grown in Ham's F-12 Nutrient Mixture supplemented with 1 mM L-glutamine and 10 % heat-inactivated fetal bovine serum (Life Technologies). Cells were maintained at 37 o C in 5 % CO 2 . CHO-pcDNA cells were obtained by stable transfection of parent null vector pcDNA3.1/Neo(+) into CHO-K1 cells; herein CHO-pcDNA cells will be referred to simply as CHO-K1. CHO-Bcl-x L cells were obtained by stable transfection of the expression vector pBcl-xL-neo as previously described (Chiang and Sisk 2005) . Expression vectors for pYFP-Bcl-x L and pHcRed-Bcl-x L encoding YFP-Bclx L or HcRed-Bcl-x L fusion proteins were created by PCR amplification of YFP and HcRed from pEYFP-C1 or pHcRed-N1 vectors, respectively (Clonetech), and ligation into pBcl-x L -neo. CHO-YFP and CHO-HcRed cells were obtained by transfecting pEYFP-C1 or pHcRed-N1 into CHO-K1 cells. Human Bcl-x L ΔBH4 (lacking amino acids 2-24) or Bcl-x L ΔTM (lacking amino acids 205-233) proteins constructs, kindly provided by J.M. Hardwick (Johns Hopkins University, Baltimore, MD), were PCR amplified and ligated into pcDNA4/HisMax. All plasmids were stably transfected into CHO-K1 cells using PolyJet (SignaGen) or Lipofectamine 2000 (Life Technologies). Selection in the presence of G418 was used to obtain all stable clones. PepMute siRNA transfection reagent (SignaGen Laboratories) was used to transfect cells with inactive (CNT) or active siRNA targeting IP 3 R3. Sense sequences for siRNA were previously described (Hayashi and Su 2007) .
Subcellular fractionation
MAM was prepared as described previously (Vance 1990) . Following homogenization of CHO-K1 or CHO-Bcl-x L cells grown on 15-cm dishes, the nuclear/whole cell (P1), crude mitochondrial, and microsomal fractions (P3) were prepared by differential centrifugation. Supernatants were collected as the cytosolic fraction. The crude mitochondrial fraction in isolation buffer (250 mM mannitol, 5 mM HEPES, 0.5 mM EGTA, pH 7.4) was subjected to Percoll gradient centrifugation for separation of the MAM from mitochondria. Once all fractions were collected, protein concentration in each sample was assessed using a BCA protein assay kit (ThermoFisher Scienific). Samples were then boiled in 2X sample buffer and equal amounts of total protein from each fraction were analyzed by SDS-PAGE and western blotting.
Pull-down assays
CHO-Bcl-x L transiently transfected with IP 3 R3 were incubated in 1X TN lysis buffer (50 mM Tris-HCl at pH 7.4, 150 mM NaCl, and 1 % Triton X-100, pH 7.4) for 30 min on ice. Cells were harvested in lysis buffer and rotated for 15 min at 4 o C. After centrifugation at 12,000 × g, the supernatant was precleared with Sepharose protein A beads (GE Healthcare) and incubated overnight with primary anti-IgG or anti-Bcl-x L antibodies at 4 o C. The lysate was then incubated with Sepharose protein A beads for 90 min at 4 o C. After washing with lysis buffer, protein concentration was assessed using a BCA protein assay kit. Immunoprecipitants were then boiled in 2X sample buffer, and equal amounts of total protein from each sample was analyzed by SDS-PAGE and western blotting.
CHO-K1 cells transiently transfected with pcDNA4-Bclx L (His-tagged Bcl-x L ) were seeded on 6-well plates until 100 % confluent. Cells were washed twice with PBS and incubated in 1X TN lysis buffer for 30 min on ice. Then cells were harvested and rotated for 15 min at 4 o C. After centrifugation at 12,000 × g, supernatants were incubated with 30 μl ProBond Ni 2+ − Chelating Resin (Life Technologies) for 90 min at 4 o C. Resin was washed three times with lysis buffer (pH 6). After samples were analyzed for protein concentration (Bradford protein assay; ThermoFisher Scentific), equal amounts of total proteins from each sample were evaluated by SDS-PAGE and western blotting.
Ca 2+ flux experiments
Control (CHO-YFP or CHO-HcRed) and Bcl-x L overexpressing (CHO-YFP-Bcl-x L or CHO-HcRed-Bcl-x L ) cells were cocultured on coverslips with poly-D-lysine coating. Additionally, null (non-siRNA treated) and siRNA treated (CNT or IP 3 R3, and pEYFP-C1 or pHcRed-N1) cells were cocultured on coverslips with poly-D-lysine coating. ER Ca 2+ was labeled using a FRET-based sensor D1ER Ca 2+ cameleon in pcDNA3 (kindly donated by R.Y. Tsien, University of California); characterization of D1ER was reported previously (Palmer et al. 2004) . Cells were transfected with D1ER 24 h prior to imaging. YFP and CFP intensities were corrected for background and net FRET (nF) fluorescence was previously defined as follows (Palmer and Tsien 2006; Xia and Liu 2001) :
Where I FRET , I YFP , and I CFP are fluorescence intensities under FRET, YFP, and CFP filter sets respectively. Bleed-through constants, YFP bleed-through and CFP bleed-through , are the percentage of YFP or CFP, respectively, detected under the FRET filter set. Cytosolic and mitochondrial Ca 2+ was labeled using Fluo-4 AM and X-Rhod-5f AM Ca 2+ dyes, respectively. Cells were incubated in dye for 20 min followed by washing (15 min) or transfected with GCaMP5 24 h prior to imaging. Ca 2+ flux as a measure of fluorescence intensity (F) was determined by capturing images every minute for 30 min using a spinning disk confocal system (Ultraview, PerkinElmer) and inverted microscope (Nikon Eclipse TE2000-E), and a 60× (NA 1.4) or 40× (NA 1.3) oil objective, while perfusing with Krebs-HEPES Buffer (KHB) containing 100 mM HEPES, 640 mM NaCl, 12.5 mM KCl, 5 mM Mg Cl 2 , 80 mM glucose and 1.5 mM CaCl 2 , or KHB without Ca 2+ and 0.5 mM LaCl3.
Metabolic assays
CHO-K1 and CHO-Bcl-x L cells suspended in IF-M2 media (Biolog) supplemented with 0.3 mM glutamine were seeded (20,000 cells/well) onto Phenotype Microarray PM-M1 plates (Biolog, Hayward, CA) containing 91 carbon-energy sources. Cells were incubated at 37 o C and 5 % CO 2 for 2 h until glutamine was depleted; thus the metabolites contained in each well of the PM-M1 plates became the sole nutrient source for the cells. Cells were then incubated for an additional 12 h in an OmniLog automated incubator-reader (Biolog) at 37 o C with Redox Dye Mix MB (Biolog), a tetrazolium-based dye. During this incubation period, metabolite utilization was measured as a function of NADH flux, which in return is based on the rate of dye reduction (Berridge et al. 2005) . Wells containing glucose served as a positive control, while wells containing tricarballylic acid functioned as a negative control since it hinders the conversion of citrate in the TCA cycle (Russell and Forsberg 1986 ). Since we were interested in the mitochondrial bioenergetic differences between CHO-K1 and CHO-Bcl-x L , utilization rates of 9 key metabolites known to feed into the TCA cycle were analyzed (see figure  legend) . Metabolite utilization for all substrates was normalized to the slope of glucose consumption. Lactate was measured from media samples taken from CHO-K1 and CHOBcl-x L cells seeded in 6-well plates after 48 h. Cells were then washed with PBS and cultured in glucose-free DMEM media (Life Technologies) for 30 min. Media was then supplemented with 6 mM D-glucose. Culture media samples were collected every 30 min and diluted 5 times with 150 mM Tris-HCl (pH 8.8).
Diluted culture media and standards were placed on clear 96-well plates and incubated at room temperature for 20 min. L-lactate was assayed by addition of 100 μl of color reagent per well: 2 mM 2-(p-Iodophenyl)-3-(pnitrophenyl)-5-phenyltetrazolium chloride, 3 mM NAD + , 2 mM ml L-lactate/ml L-lactate dehydrogenase. Absorbance was measured at 550 nm using a Genios plate reader (TECAN).
An NAD/NADH Quantitation Kit (Sigma-Aldrich) was used to measure NAD total (total NADH and NAD) and NADH in CHO-K1 and CHO-Bcl-x L cell lysates according to the manufacture's instructions. Standards and samples were colorimetrically assayed on clear 96-well plates using a Genios plate reader (TECAN) at 450 nm. A chemiluminescence assay was used to measure electron transport chain oxidoreductase (ETC oxidase) activity in CHO-K1 and CHOBcl-x L cells harvested in PBS. Suspended cells (5-6 × 10 5 cells per well) were placed on white 96-well plates with solution containing PBS and 20 μM lucigenin and luminescence was monitored for 5 min using VICTOR 3 plate reader (PerkinElmer). Following NADH (45 μM) stimulation (Lu et al. 2007; Michel et al. 1998) , luminescence was additionally monitored for 60 min.
Cellular stress assays
CHO-K1 and CHO-Bcl-x L cells were cultured on sterile black 96-well plates and pretreated with 500 nM Tg, 3 μM staurosporine (STA) or 50 μM camptothecin (Camp). Apoptosis was then analyzed using an Annexin V FITC Assay Kit (Cayman Chemical) or a Caspase-Glo Assay Kit (Promega) using either a VICTOR 3 plate reader (PerkinElmer) or a Genios plate reader (TECAN), respectively.
Immunostaining CHO-Bcl-x L cells were transiently transfected with GFP-mito (pAcGFP1-mito; Clonetech) or DsRed-mito (pDsRed2-mito; Clonetech) mitochondrial markers and grown on coverslips with poly-D-lysine coating. After fixation with 4 % paraformaldehyde in 0.1 M phosphate buffer, cells were permeabilized with 0.2 % Triton X-100 or 0.1 % NP-40 for 10 min. Cells were then incubated with 10 % nonfat milk to block against non-specific binding of antibodies. Fixed cells were then incubated with monoclonal Tomm20 (translocase of outer mitochondrial membrane 20; Abcam), monoclonal Bcl-x L (Cell Signaling Technology), polyclonal Sig-1R (previously described in, (Hayashi and Su 2007) polyclonal BiP (BD Bioscience), monoclonal 1,4,5-trisphosphate receptor type 3 (BD Bioscience), and/or monoclonal mitofusin 2 (Abcam) antibodies. After incubation with Alexa-conjugated secondary antibodies, coverslips were mounted on coverglass. Images were analyzed using 3D confocal microscopy using a spinning disk confocal system (Ultraview, PerkinElmer) and inverted microscope (Nikon Eclipse TE2000-E) using a 100× (NA 1.4) oil objective. Colocalization coefficeints, m1 and m2, were used to quantify colocalization (Zinchuk and Grossenbacher-Zinchuk 2001) .
Live-cell imaging
CHO-K1 cells transiently transfected with YFP-Bcl-x L and DsRed-mito were grown on coverslips with poly-D-lysine coating. 24 h after transfection, cells were perfused with RPMI media containing 50 mM HEPES, 10 % FBS and 500 nM thapsigargin (Tg). Images were analyzed using 3D confocal microscopy using a spinning disk confocal system (Ultraview, PerkinElmer) and inverted microscope (Nikon Eclipse TE2000-E) using a 60× (NA 1.4) or 40× (NA 1.3) oil objective. Frames were taken every 30 min for 3 h. Colocalizaztion coefficeints, m1 and m2, were used to quantify colocalization (Zinchuk and Grossenbacher-Zinchuk 2001) .
Statistical analysis
Statistical analysis of data provided in this study was determined using analysis of variance (ANOVA) for at least three independent replicates. Values were provided as mean ± standard error of mean (SEM), and results with P < 0.05 in comparison to an indicated control were considered statistically significant.
